Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Chardan Capital Markets Downgrades Amicus Therapeutics (FOLD) to Neutral
-
Safe-T Group Ltd. (SFET) Prices 510.4K ADS Offering at $14.35/ADS
-
Safe-T Announces Pricing of $7.335 Million Underwritten Public Offering
-
Krystal Biotech Announces $10 Million Private Placement with Frazier Healthcare Partners
-
Social Reality (SRAX) PT Doubled to $10 at Chardan Capital Markets
-
Chardan Capital Markets Starts eHealth (EHTH) at Buy
-
Emergent BioSolutions (EBS) PT Raised to $60 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades Sunworks (SUNW) to Neutral
-
Homology Medicines Reports Second Quarter 2018 Financial Results
-
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Chardan Capital Markets Downgrades Globalstar (GSAT) to Neutral
-
Regenxbio Inc. (RGNX) PT Lowered to $127.50 at Chardan Capital Markets; Sees Low Bar in Wet AMD
-
Model N, Inc. (MODN) PT Raised to $24 at Chardan Capital Markets
-
Arrowhead Research (ARWR) PT Raised to $17.50 at Chardan Capital Markets
-
SRAX Closes Sale of SRAXmd and Receives $33.5 Million in Cash Plus Additional Consideration
-
Greenland Acquisition Corporation Announces that Ordinary Shares, Rights, and Warrants to Commence Separate Trading on or about August 8, 2018
-
Greenland Acquisition Corporation Announces that Ordinary Shares, Rights, and Warrants to Commence Separate Trading on or about August 8, 2018
-
Tottenham Acquisition I Limited Announces Closing of Initial Public Offering
-
Benefitfocus (BNFT) PT Raised to $36 at Chardan Capital Markets
-
Teladoc (TDOC) PT Raised to $86 at Chardan Capital Markets
-
Tottenham Acquisition I Limited (TOTAU) Prices 4M Unit IPO at $10/Unit
-
Tottenham Acquisition I Limited Announces Pricing of $40 Million Initial Public Offering
-
Chardan Capital Markets Downgrades Castlight Health Inc. (CSLT) to Neutral
-
Chardan Capital Markets Starts ADMA Biologics (ADMA) at Buy, Is Positive on Turnaround Story
-
Social Reality (SRAX) Reports Agreement to Sell SRAXmd for Up to $52.5M
-
SRAX Agrees to Sell SRAXmd for Up to $52.5 Million
-
Greenland Acquisition Corporation Announces Closing of $44 Million Initial Public Offering
-
Greenland Acquisition Corporation Announces Closing of $44 Million Initial Public Offering
-
OncoCyte (OCX) Announces At-Market $3.59 Million Offering of Common Stock, Warrants
-
ContraFect (CFRX) Prices 5M Share Public Offering of Common Stock at $2/Sh
-
ContraFect Corporation Prices $10 Million Public Offering of Common Stock
-
OncoCyte Announces At-Market $3.59 Million Offering of Common Stock and Warrants
-
Priority Holdings, LLC Completes Combination with M I Acquisitions, Inc.
-
Greenland Acquisition Corporation (GLAC) Prices 4M Share IPO at $10/Sh
-
Greenland Acquisition Corporation Announces Pricing of $40 Million Initial Public Offering
-
Greenland Acquisition Corporation Announces Pricing of $40 Million Initial Public Offering
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Thunder Bridge Acquisition, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 17, 2018
-
Regenxbio Inc. (RGNX) PT Raised to 'Street High' $130 at Chardan Capital Markets
-
Allegro Merger Corp. Announces Closing of $149,500,000 Initial Public Offering
-
Allegro Merger Corp. Announces Closing of $149,500,000 Initial Public Offering
-
BioSig Technologies (BSGM): Buy Ahead Of Initial Product Launch - Chardan
-
Iovanace Biotherapeutics (IOVA) PT Maintained at $30 at Chardan Capital Markets; 'Market Misunderstandings' Offer 'Buying Opportunity Ahead of Data'
-
Chardan Capital Markets Starts Dynamic Materials (BOOM) at Buy
-
Profire Energy, Inc. Announces Completion of Secondary Public Offering
-
Allegro Merger Corp. (ALGRU) Prices 13M Unit IPO at $10/Unit
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Arrowhead Research (ARWR) PT Raised to $16 at Chardan Capital Markets
-
Profire Energy (PFIE) Prices 7.5M Share Secondary Public Offering of Common Stock at $3.25/Sh

